Bacteriological Evaluation of Children With Otorrhea
ConditionOtorrhea
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age3-15
SponsorAssociation Clinique Thérapeutique Infantile du val de Marne
About this trial
After pneumococcal conjugate vaccine implementation, the number of acute otitis media (AOM) episodes has decreased, but AOM still remains among the most common diagnoses in childhood. From 2% to 17% of cases of AOM feature spontaneous perforation of the tympanic membrane (SPTM). The aim of this study was to describe the bacteriological causes of SPTM several years after PCV13 implementation, in 2010.
Eligibility criteria
Qualifiers
children from 3 months to 15 years old
with otorrhea
signed parents consent
Disqualifiers
children under 3 months
children > 15 years old
Trial design
Treatments tested in this trial
- middle ear fluid sample for bacterial analysis (conventional microbiology analysis)
Treatment groups
1,500 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov